Menu
Recruiting NCT07379723

Brief Intervention for FCD: A Feasibility Study

No phase Interventional Functional Cognitive Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Brief psychological intervention including attention training.
Who it may be relevant to
Registry conditions: Functional Cognitive Disorder. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Feasibility Pilot Study of a Brief Intervention in Functional Cognitive Disorder

Overview

The goal of this study is to learn if a single session intervention for people with Functional Cognitive Disorder (FCD) is feasible and acceptable. The main questions it aims to answer are: What is the impact of a single session intervention on FCD symptoms, functional impairment, and quality of life in people with FCD? What is the feasibility and acceptability of piloting a single session intervention for people with FCD. Participants will: * Complete questionnaires about cognitive concerns, anxiety, depression, functional impairment and quality of life * Visit the clinic for a single session intervention including practicing the Attention Training Technique (ATT) * Complete 2 telephone calls with a researcher to discuss their use of the intervention and to complete the same questionnaires from their clinic visit, and a questionnaire about their experience of the study and intervention.

Interventions

  • Behavioral Brief psychological intervention including attention training
    Brief psychological intervention including attention training

Primary outcome measures

  • Participant recruitment, feasibility and retention from baseline to follow-up [Time frame: From enrollment to follow-up 6 weeks post-intervention.]
Secondary outcome measures (6)
  • Acceptability of the study intervention at follow-up [Time frame: Post-intervention follow-up at 6 weeks.]
  • Change in symptoms of depression from enrolment to post-intervention follow-up [Time frame: At enrolment and at follow-up 6 weeks post-intervention]
  • Change in symptoms of anxiety from enrolment to post-intervention follow-up [Time frame: At enrolment and at follow-up 6 weeks post-intervention]
  • Change in functional impairment from enrolment to post-intervention follow-up [Time frame: At enrolment and at follow-up 6 weeks post-intervention]
  • Change in quality of life from enrolment to post-intervention follow-up [Time frame: At enrolment and at follow-up 6 weeks post-intervention]
  • Change in self-reported cognitive symptoms from enrolment to post-intervention follow-up [Time frame: At enrolment and at follow-up 6 weeks post-intervention]

Eligibility criteria

Inclusion criteria

  • Adults aged 65 or below
  • Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service)
  • Not taking part in any other intervention study or trial

Exclusion criteria

  • Aged above 65 years
  • Lack capacity to consent
  • MRI results not in normal range
  • Neurological diagnosis
  • Indication of severe low mood or depression (from clinical interview, routine measures)
  • Taking part in any other intervention study or trial

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United Kingdom · 1 center
  • King's College Hospital — London

Identifiers

NCT: NCT07379723 · IRAS Reference: 354504

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗